[
  {
    "ts": "2026-02-08T02:50:00+00:00",
    "headline": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
    "summary": "Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.",
    "url": "https://www.fool.com/investing/2026/02/07/missed-out-on-eli-lilly-2-healthcare-stocks-with-b/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "a08c7e4e-8a72-3a9a-b75a-cde4b13f162d",
      "content": {
        "id": "a08c7e4e-8a72-3a9a-b75a-cde4b13f162d",
        "contentType": "STORY",
        "title": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
        "description": "",
        "summary": "Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.",
        "pubDate": "2026-02-08T02:50:00Z",
        "displayTime": "2026-02-08T02:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/383956ea2a3a89f7dac1614dd83af11c",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "A person standing with a u turn sign on the ground in front of them.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lk9o0Tx5YvpuHb5Qc06p6g--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/383956ea2a3a89f7dac1614dd83af11c.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BjS5VenDjPwIxE625D2yzQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/383956ea2a3a89f7dac1614dd83af11c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/07/missed-out-on-eli-lilly-2-healthcare-stocks-with-b/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/missed-eli-lilly-2-healthcare-025000620.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-08T10:05:00+00:00",
    "headline": "Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology",
    "summary": "Innovent Biologics, Inc. (\"Innovent\") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, today announced a strategic collaboration with Eli Lilly and Company (\"Lilly\") to advance novel medicines in oncology and immunology. This agreement marks the seventh collaboration between the two companies, deepening a",
    "url": "https://finance.yahoo.com/news/innovent-announces-strategic-collaboration-lilly-100500309.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "34b5a86a-bf34-365b-918c-eba3e2090535",
      "content": {
        "id": "34b5a86a-bf34-365b-918c-eba3e2090535",
        "contentType": "STORY",
        "title": "Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology",
        "description": "",
        "summary": "Innovent Biologics, Inc. (\"Innovent\") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, today announced a strategic collaboration with Eli Lilly and Company (\"Lilly\") to advance novel medicines in oncology and immunology. This agreement marks the seventh collaboration between the two companies, deepening a",
        "pubDate": "2026-02-08T10:05:00Z",
        "displayTime": "2026-02-08T10:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/9ffd7989dfba6052a90df6efa1d987f0",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ff3oWoarY5PF9WTlrryYRw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/9ffd7989dfba6052a90df6efa1d987f0.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0.nAM34y0RYphEhkxzt1Fg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/9ffd7989dfba6052a90df6efa1d987f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/innovent-announces-strategic-collaboration-lilly-100500309.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/innovent-announces-strategic-collaboration-lilly-100500309.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IVBIY"
            },
            {
              "symbol": "IVBXF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]